SCHEMBL8333655

SCHEMBL8333655

CNC(=S)N(C(=O)C(C)c1ccc(OC)c(N=S(=O)=O)c1)C1C2CC3CC(C2)CC1C3

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8340998 0.92 PKM (0.31) —
SCHEMBL8341070 0.88 — —
SCHEMBL8339599 0.84 TSHR (0.36) —
SCHEMBL8336673 0.82 CNR2 (0.35) —
SCHEMBL8333062 0.81 GAA (0.36) —
SCHEMBL8335857 0.81 GAA (0.31) —
SCHEMBL8334835 0.81 GAA (0.31) —
SCHEMBL8864409 0.80 KMT2A (0.31) —
SCHEMBL8334767 0.78 ALDH1A1 (0.33) —
SCHEMBL8333752 0.78 HIF1A (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5977177-A Substituted benzenesulfonylureas and-thioureas, processes for their preparation and use of pharmaceutical preparations based on these compounds, and medicaments containing them HOECHST AKTIENGESELLSCHAFT (DE) 1999-11-02 — — US disclosed
US-5880155-A TREATMENT OF CARDIOVASCULAR DISORDERS HOECHST AKTIENGESELLSCHAFT (DE) 1999-03-09 — — US disclosed
Send feedback